Clinical Practice
Copyright ©2013 Baishideng Publishing Group Co.
World J Clin Cases. Nov 16, 2013; 1(8): 249-255
Published online Nov 16, 2013. doi: 10.12998/wjcc.v1.i8.249
Table 1 Overall distribution of bacteria isolated in control and test groups n (%)
Bacteria typeControl (n = 182)
Test (n = 156)
Total
PSBN-PSBPSBN-PSB
Facultative GNB2 (1.1)17 (9.3)5 (3.2)21 (13.5)45 (13.4)
Aerobic GPB6 (3.2)11 (6.04)-20 (12.8)37 (10.9)
Aerobic GNC-9 (4.9)-8 (5.1)17 (5.02)
Facultative GPC3 (1.64)62 (34.1)6 (3.9)72 (46.2)143 (42.3)
Anaerobic GNB17 (9.3)21 (11.5)3 (1.9)-40 (11.8)
Anaerobic GPB-16 (8.8)-15 (9.6)31 (9.2)
Anaerobic GNC11 (6.04)-6 (3.9)-17 (5)
Anaerobic GPC-7 (3.8)--7 (2.1)
Totals3914320136338
Table 2 Distribution and bacteria isolated at control and test sites at baseline, 5 and 13 wk n (%)
Baseline
5 wk
13 wk
ControlTestControlTestControlTest
Actinomycesnaeslundii FG+veR3 (3.9)---1 (1.7)1 (1.6)
Actinomycesviscosus FG+veR2 (2.6)---1 (1.7)1 (1.6)
Bifidobacterium spp FG+veR4 (5.2)3 (7.1)2 (4)2 (3.6)1 (1.7)3 (4.9)
Clostridium spp FG+veR--7 (14)6 (11.3)--
Diphtheroid bacilli AG+veR2 (2.6)4 (9.5)2 (4)2 (3.6)3 (5.3)1 (1.6)
Escherichia coli FG-veR--1 (2)2 (3.6)--
Eubacterium spp FG+veR11 (1.3)--2 (3.6)--
Fusobacteriumnucleatum AnG-veR12 (2.6)-3 (6)4 (7.5)8 (14.2)-
Haemophilus spp FG-veR10 (13.1)3 (7.1)4 (8)2 (3.6)5 (8.9)3 (4.9)
Coagulase-negative Staphylococci FG+veC2 (2.6)2 (4.7)2 (4)1 (1.8)-4 (6.5)
Neisserria spp AG-veC8 (10.5)2 (4.7)2 (4)2 (3.6)1 (1.7)-
Peptostreptococcus AnG+veC5 (6.5)-----
Porphyromonasgingivalis AnG-veR1----2 (3.2)-
Prevotellaintermedia AnG-veR11 (1.3)1 (2.3)1 (2)1 (1.8)8 (14.2)-
Propionibacteriumgranulosum FG+veR-1 (2.3)----
Staphylococcus aureus FG+veC2 (2.6)1 (2.3)3 (6)7 (13.2)-2 (3.2)
Veillonellaparvula AnG-veC11 (1.3)1 (2.3)3 (6)1 (1.8)10 (17.8)1 (1.6)
Streptococci AG-veC25 (32.8)15 (35.7)15 (30)19 (35.8)11 (19.6)39 (63.9)
Campylobacter rectus FG-veR6 (7.8)4 (9.5)3 (6)-4 (7.1)2 (3.2)
Treponemadenticola AnG-veC11 (1.3)2 (4.7)1 (2)1 (1.8)--
Gemella spp FG+veC----2 (3.2)
Filifactoralocis FG+veR1 (1.3)3 (7.1)1 (2)1 (1.8)1 (1.7)2 (3.2)
Total (n)764250535661
P value0.5950.8950.0062
Table 3 Statistical data on the distribution of bacteria isolated in control and test groups for gram stain, atmosphere of growth, morphological properties and pathogenicity at baseline, 5 and 13 wk
Type of bacteriaControlTestχ2P value
Baseline
Aerobic/facultative55714.9130.0839
Anaerobic4529
Gram-positive69712.3910.00521
Gram-negative3129
Cocci72582.5980.00181
Rods2842
5 wk
Aerobic/facultative60620.7210.02511
Anaerobic4038
Gram-positive75750.5930.01341
Gram-negative2525
Cocci65510.3980.00311
Rods3545
13 wk
Aerobic/facultative43855.8210.00511
Anaerobic5715
Gram-positive39806.3210.00321
Gram-negative6120
Cocci38557.2290.00051
Rods7235
Table 4 Distribution of bacteria isolated in the control group at baseline, 5 and 13 wk
TimeBacteria (control group)
Bacteria (test group)
AnaerobicGram-negativeRod-shapedAnaerobicGram-negativeRod-shaped
Baseline45%31%28%29%29%42%
5 wk40%25%35%38%25%45%
13 wk57%61%72%15%20%35%
26.0222.0915.41210.1715.0216.118
P value0.0890.02110.0980.0810.2850.192